Drugs / mRNA-1283.222
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05815498 | Mar 2023 → Apr 2025 | COVID-19 | ModernaTX, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA-1283.222 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05815498 ↗ |
| Route | Intramuscular | “single intramuscular (IM) injection of mRNA-1283.222” NCT05815498 ↗ |